Financials
Preliminary Results for the year ended 31 Dec 2023 | Jun. 13, 2024 |
Business Update | Mar. 13, 2024 |
Interim Results | Sep. 28, 2023 |
Preliminary Results for the year ended 31 Dec 2022 | May. 31, 2023 |
Half-year Report | Sep. 30, 2022 |
Final Results | May. 12, 2022 |
PDS Provides Business Update & Full-Year Results | Mar. 31, 2022 |
Proxies
Result of AGM | Jul. 10, 2024 |
Notice of AGM | Jun. 18, 2024 |
Result of AGM & Board Changes | Jun. 29, 2023 |
Notice of AGM | Jun. 06, 2023 |
Result of AGM | Jun. 29, 2022 |
Notice of AGM and Annual Report & Accounts | Jun. 07, 2022 |
Result of AGM | Jun. 03, 2021 |
Ownership Update
TR-1 | Jun. 14, 2024 |
Director/PDMR Shareholding | Jun. 14, 2024 |
Director/PDMR Shareholding | Nov. 13, 2023 |
Director/PDMR Shareholding | Jun. 07, 2023 |
Holding(s) in Company | Jun. 28, 2022 |
Holding(s) in Company | Jun. 27, 2022 |
Director/PDMR Shareholding | Jun. 27, 2022 |
Announcements
PDS: Updated Results, VERSATILE-002 Phase 2 Trial | Sep. 16, 2024 |
PDS Biotech: Business Update and Q2 2024 Results | Aug. 13, 2024 |
Replacement RNS: PDS Biotech Aligns with FDA | Aug. 02, 2024 |
PDS Biotech Aligns with FDA on Phase 3 Trial | Aug. 02, 2024 |
Q-Bot Fundraising | Jul. 30, 2024 |
Notice of Results and Investor Presentation | May. 31, 2024 |
DeepTech Recycling: Fundraising, Business Update | May. 31, 2024 |